Topic

Buprenorphine

NJSPL Report: Reducing Opioid Overdose Risk in New Jersey

Researchers found that incidents of NJ Medicaid beneficiaries who received buprenorphine immediately and/or shortly after an opioid-related emergency department visit increased from 4.0% in 2018 to 14.4% in 2022. The team also conducted a series of interviews with medical professionals and discussed the challenges to buprenorphine provision, including patient resistance, insurance and pharmacy obstacles, and limited training and stigmatization.

Topics